What is folic acid (Vitamin B9) given for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Folic Acid is Given For

Folic acid is primarily given to prevent neural tube defects in women of childbearing age, treat megaloblastic anemia due to folate deficiency, and support rapid cell division during pregnancy, infancy, and childhood. 1, 2

Primary Indications

Prevention of Neural Tube Defects

  • All women capable of becoming pregnant should take 400 mcg (0.4 mg) of folic acid daily, starting before conception and continuing through the first trimester 1
  • Women with a previous pregnancy affected by neural tube defects require 4 mg daily 1
  • This supplementation reduces neural tube defects by approximately 48-89% (odds ratios ranging from 0.11 to 0.67 across studies) 1
  • The mechanism involves folic acid's essential role in DNA synthesis, methylation reactions, and purine/pyrimidine synthesis during critical embryonic neural tube closure 1, 3

Treatment of Megaloblastic Anemia

  • Folic acid 1-5 mg daily orally for four months effectively treats megaloblastic anemia due to folate deficiency 1, 2
  • Indicated for anemias of nutritional origin, tropical/nontropical sprue, pregnancy, infancy, or childhood 2
  • Symptoms include macrocytic anemia, pancytopenia, glossitis, angular stomatitis, oral ulcers, and neuropsychiatric manifestations (depression, irritability, cognitive impairment) 1

Nutritional Support in High-Risk Populations

  • Preterm and term infants on parenteral nutrition: 56 mcg/kg/day up to 12 months, then 140 mcg/day for older children 1
  • Chronic hemodialysis patients: 1-5 mg daily orally 1
  • Patients with malabsorption syndromes, rapid growth periods, or increased erythropoiesis 1

Critical Safety Considerations

Vitamin B12 Deficiency Screening

  • Always evaluate for vitamin B12 deficiency before starting folic acid supplementation 1, 4, 2
  • Folic acid can mask the hematologic manifestations of B12 deficiency while allowing irreversible neurological damage to progress 1, 4, 2
  • The upper limit for folic acid is set at 1 mg/day specifically to avoid masking B12 deficiency 1, 4
  • This risk is minimal in young women (less than 1% have B12 levels <100 pg/mL), but screening remains essential 1

Monitoring Protocol

  • Measure serum or red blood cell folate at baseline using methods validated against microbiological assay 1, 4
  • Consider measuring homocysteine simultaneously to improve interpretation 1, 4
  • Repeat folate measurements within 3 months after starting supplementation to verify normalization 1, 4
  • Once normalized, monitor every 3 months until stabilization, then annually 1, 4

Dosing by Clinical Scenario

Dietary Deficiency or Chronic Hemodialysis

  • 1-5 mg folic acid daily orally for four months or until the underlying cause is corrected 1
  • If oral administration is ineffective, use 0.1 mg/day parenterally (subcutaneous, IV, or IM) 4

Women of Childbearing Age

  • 0.4-0.8 mg daily for women planning pregnancy without prior neural tube defect history 1
  • 0.4 mg daily for all women of childbearing age not planning pregnancy 1
  • 4 mg daily for women with previous neural tube defect-affected pregnancy 1
  • Women on antiepileptic drugs require at least 0.4 mg daily due to impaired folate metabolism 1

Pediatric Parenteral Nutrition

  • 56 mcg/kg/day for infants up to 12 months 1
  • 140 mcg/day for children over 12 months 1

Common Pitfalls to Avoid

  • Never give folic acid alone for pernicious anemia or other B12-deficient megaloblastic anemias—this is improper therapy per FDA labeling 2
  • Do not assume food fortification eliminates the need for supplementation in high-risk populations 1
  • Recognize that isolated clinical folate deficiency is extremely rare in Western countries; always consider underlying causes listed in deficiency risk factors 1
  • Be aware that excess folic acid is excreted in urine, and oral administration at recommended doses is considered non-toxic 1
  • Historical concerns about folic acid increasing twinning rates have been disproven after adjusting for fertility treatments 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Folic Acid Supplementation for Williams Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.